This finding perhaps is reflected by the variation in KLK4 expression levels during PCa progression obtained from various transcriptomic datasets showing a decreasing expression with progression of prostate tumors as well as a lower expression in PCa-metastasis compared to primary PCa (Figure 1). Here, KLK4 is linked to prostate neoplasm.